| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.33 | 1e-19 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-16 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.3 | 7e-16 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.4 | 1e-14 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-14 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-14 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.27 | 1e-13 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.25 | 8e-12 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-10 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-09 |